We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Acetaminophen Use Could Double the Risk of Asthma in Juveniles

By HospiMedica International staff writers
Posted on 30 Aug 2010
Acetaminophen use in adolescents is linked to the development and continuance of asthma, rhino-conjunctivitis, and eczema, according to a new study.

Researchers at the Medical Research Institute of New Zealand (Wellington) conducted a study at 113 centers in 50 countries participating in the International Study of Asthma and Allergies in Childhood (ISAAC), investigating the risk related to acetaminophen use in adolescents; 322,959 children (aged 13-14 years old) completed written and video questionnaires regarding their current symptoms of asthma, rhinoconjunctivitis, and eczema. More...
They also completed a written environmental questionnaire regarding potential risk factors (including acetaminophen exposure) in the preceding 12 months. The primary outcome measure was the odds ratio (OR) of current asthma symptoms associated with acetaminophen use, calculated by logistic regression.

The results showed that recent use of acetaminophen was associated with an exposure-dependent OR risk of 1.43 for current asthma symptoms, and an OR risk of 2.51 for medium and high asthma development. Acetaminophen use was also associated with an exposure-dependent increased risk of current symptoms of rhinoconjunctivitis and eczema. The study was published early online on August 13, 2010, in the American Journal of Respiratory and Critical Care Medicine.

"The overall population attributable risks for current symptoms of severe asthma were around 40%, suggesting that if the associations were causal, they would be of major public health significance,” said lead author professor of medicine Richard Beasley, M.D., director of the Medical Research Institute of New Zealand. "Randomized controlled trials are now urgently required to investigate this relationship further and to guide the use of antipyretics, not only in children but in pregnancy and adult life.”

Acetaminophen, also known as Paracetamol, is a widely used over-the-counter (OTC) analgesic and antipyretic. It is commonly used for the relief of headaches and other minor aches and pains, and is a major ingredient in numerous cold remedies. While generally safe for use at recommended doses, acute overdoses of acetaminophen can cause potentially fatal liver damage and, in rare individuals, a normal dose can do the same; the risk is heightened by alcohol consumption.

Related Links:
Medical Research Institute of New Zealand



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.